STAT3 and hepatocellular carcinoma: Finally, it has been demonstrated that natural killer (NK) cells mediate the antitumor effect of liraglutide in HCC, as liraglutide enhances NK cell-mediated oncolytic activity by suppressing the IL-6/STAT3 signaling pathway in HCC [64] (Figure 2).